DK239490D0 - Kontrastmidler til magnetisk resonansafbildning - Google Patents

Kontrastmidler til magnetisk resonansafbildning

Info

Publication number
DK239490D0
DK239490D0 DK239490A DK239490A DK239490D0 DK 239490 D0 DK239490 D0 DK 239490D0 DK 239490 A DK239490 A DK 239490A DK 239490 A DK239490 A DK 239490A DK 239490 D0 DK239490 D0 DK 239490D0
Authority
DK
Denmark
Prior art keywords
magnetic
resonance image
contrast
magnetic resonance
contrast magnetic
Prior art date
Application number
DK239490A
Other languages
English (en)
Other versions
DK239490A (da
Inventor
Arne Berg
Jo Klaverness
Original Assignee
Nycomed As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nycomed As filed Critical Nycomed As
Publication of DK239490A publication Critical patent/DK239490A/da
Publication of DK239490D0 publication Critical patent/DK239490D0/da

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01R—MEASURING ELECTRIC VARIABLES; MEASURING MAGNETIC VARIABLES
    • G01R33/00—Arrangements or instruments for measuring magnetic variables
    • G01R33/20—Arrangements or instruments for measuring magnetic variables involving magnetic resonance
    • G01R33/44—Arrangements or instruments for measuring magnetic variables involving magnetic resonance using nuclear magnetic resonance [NMR]
    • G01R33/48—NMR imaging systems
    • G01R33/54—Signal processing systems, e.g. using pulse sequences ; Generation or control of pulse sequences; Operator console
    • G01R33/56—Image enhancement or correction, e.g. subtraction or averaging techniques, e.g. improvement of signal-to-noise ratio and resolution
    • G01R33/5601—Image enhancement or correction, e.g. subtraction or averaging techniques, e.g. improvement of signal-to-noise ratio and resolution involving use of a contrast agent for contrast manipulation, e.g. a paramagnetic, super-paramagnetic, ferromagnetic or hyperpolarised contrast agent
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/06—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations
    • A61K49/08—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by the carrier
    • A61K49/10—Organic compounds
    • A61K49/101—Organic compounds the carrier being a complex-forming compound able to form MRI-active complexes with paramagnetic metals
    • A61K49/103—Organic compounds the carrier being a complex-forming compound able to form MRI-active complexes with paramagnetic metals the complex-forming compound being acyclic, e.g. DTPA
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/06—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations
    • A61K49/08—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by the carrier
    • A61K49/10—Organic compounds
    • A61K49/12—Macromolecular compounds
    • A61K49/126—Linear polymers, e.g. dextran, inulin, PEG
    • A61K49/128—Linear polymers, e.g. dextran, inulin, PEG comprising multiple complex or complex-forming groups, being either part of the linear polymeric backbone or being pending groups covalently linked to the linear polymeric backbone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/06—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations
    • A61K49/18—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by a special physical form, e.g. emulsions, microcapsules, liposomes
    • A61K49/1818—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by a special physical form, e.g. emulsions, microcapsules, liposomes particles, e.g. uncoated or non-functionalised microparticles or nanoparticles
    • A61K49/1821—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by a special physical form, e.g. emulsions, microcapsules, liposomes particles, e.g. uncoated or non-functionalised microparticles or nanoparticles coated or functionalised microparticles or nanoparticles
    • A61K49/1824—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by a special physical form, e.g. emulsions, microcapsules, liposomes particles, e.g. uncoated or non-functionalised microparticles or nanoparticles coated or functionalised microparticles or nanoparticles coated or functionalised nanoparticles
    • A61K49/1827—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by a special physical form, e.g. emulsions, microcapsules, liposomes particles, e.g. uncoated or non-functionalised microparticles or nanoparticles coated or functionalised microparticles or nanoparticles coated or functionalised nanoparticles having a (super)(para)magnetic core, being a solid MRI-active material, e.g. magnetite, or composed of a plurality of MRI-active, organic agents, e.g. Gd-chelates, or nuclei, e.g. Eu3+, encapsulated or entrapped in the core of the coated or functionalised nanoparticle
    • A61K49/1851—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by a special physical form, e.g. emulsions, microcapsules, liposomes particles, e.g. uncoated or non-functionalised microparticles or nanoparticles coated or functionalised microparticles or nanoparticles coated or functionalised nanoparticles having a (super)(para)magnetic core, being a solid MRI-active material, e.g. magnetite, or composed of a plurality of MRI-active, organic agents, e.g. Gd-chelates, or nuclei, e.g. Eu3+, encapsulated or entrapped in the core of the coated or functionalised nanoparticle having a (super)(para)magnetic core coated or functionalised with an organic macromolecular compound, i.e. oligomeric, polymeric, dendrimeric organic molecule
    • A61K49/1863—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by a special physical form, e.g. emulsions, microcapsules, liposomes particles, e.g. uncoated or non-functionalised microparticles or nanoparticles coated or functionalised microparticles or nanoparticles coated or functionalised nanoparticles having a (super)(para)magnetic core, being a solid MRI-active material, e.g. magnetite, or composed of a plurality of MRI-active, organic agents, e.g. Gd-chelates, or nuclei, e.g. Eu3+, encapsulated or entrapped in the core of the coated or functionalised nanoparticle having a (super)(para)magnetic core coated or functionalised with an organic macromolecular compound, i.e. oligomeric, polymeric, dendrimeric organic molecule the organic macromolecular compound being a polysaccharide or derivative thereof, e.g. chitosan, chitin, cellulose, pectin, starch
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T436/00—Chemistry: analytical and immunological testing
    • Y10T436/24—Nuclear magnetic resonance, electron spin resonance or other spin effects or mass spectrometry

Landscapes

  • Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Nanotechnology (AREA)
  • Radiology & Medical Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Physics & Mathematics (AREA)
  • Medicinal Chemistry (AREA)
  • Condensed Matter Physics & Semiconductors (AREA)
  • High Energy & Nuclear Physics (AREA)
  • General Physics & Mathematics (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Signal Processing (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Magnetic Resonance Imaging Apparatus (AREA)
DK239490A 1988-04-08 1990-10-04 Kontrastmidler til magnetisk resonansafbildning DK239490D0 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB888808305A GB8808305D0 (en) 1988-04-08 1988-04-08 Compositions
PCT/EP1989/000376 WO1989009625A1 (en) 1988-04-08 1989-04-06 Contrast agents for magnetic resonance imaging

Publications (2)

Publication Number Publication Date
DK239490A DK239490A (da) 1990-10-04
DK239490D0 true DK239490D0 (da) 1990-10-04

Family

ID=10634845

Family Applications (1)

Application Number Title Priority Date Filing Date
DK239490A DK239490D0 (da) 1988-04-08 1990-10-04 Kontrastmidler til magnetisk resonansafbildning

Country Status (8)

Country Link
US (1) US5128121A (da)
EP (1) EP0414700B1 (da)
JP (1) JPH082802B2 (da)
AU (1) AU624132B2 (da)
DE (1) DE68909935T2 (da)
DK (1) DK239490D0 (da)
GB (1) GB8808305D0 (da)
WO (1) WO1989009625A1 (da)

Families Citing this family (78)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MX12394A (es) * 1987-07-23 1993-12-01 Ciba Geigy Ag Procedimiento par la obtencion de carbamatos de polietilenglicol.
GB8830215D0 (en) * 1988-12-23 1989-02-22 Hafslund Nycomed Innovation Method
US5393525A (en) * 1989-07-21 1995-02-28 Nycomed Imaging As Contrast medium comprising superparamagnetic or ferromagnetic particles capable of increasing viscosity after administration
US5190744A (en) * 1990-03-09 1993-03-02 Salutar Methods for detecting blood perfusion variations by magnetic resonance imaging
US5494655A (en) * 1990-03-09 1996-02-27 The Regents Of The University Of California Methods for detecting blood perfusion variations by magnetic resonance imaging
US5358702A (en) * 1990-04-10 1994-10-25 Unger Evan C Methoxylated gel particle contrast media for improved diagnostic imaging
US5948384A (en) * 1990-09-14 1999-09-07 Syngenix Limited Particulate agents
AU8514291A (en) * 1990-09-14 1992-04-15 St. George's Enterprises Limited Particulate agents
GB9020075D0 (en) 1990-09-14 1990-10-24 Filler Aaron G Contrast agents for magnetic resonance imaging of axonal transport
US6919067B2 (en) 1991-09-13 2005-07-19 Syngenix Limited Compositions comprising a tissue glue and therapeutic agents
US5676689A (en) * 1991-11-08 1997-10-14 Kensey Nash Corporation Hemostatic puncture closure system including vessel location device and method of use
US5282827A (en) * 1991-11-08 1994-02-01 Kensey Nash Corporation Hemostatic puncture closure system and method of use
JPH07501331A (ja) * 1991-11-19 1995-02-09 イマアーレクス・フアーマシユーチカル・コーポレーシヨン 改良された診断用の造影のためのゲル粒子造影剤
DE4218321A1 (de) * 1991-12-09 1993-06-17 Siemens Ag Diagnostikanlage
JPH07507800A (ja) * 1992-06-15 1995-08-31 ボード・オヴ・リージェンツ，ザ・ユニヴァーシティ・オヴ・テキサス・システム 胃腸管用造影剤としての粘土に封入された遷移および希土類金属イオン
US5323780A (en) * 1992-08-07 1994-06-28 University Of Florida Research Foundation, Inc. Artifact-free imaging contrast agent
US5532006A (en) * 1993-04-23 1996-07-02 The Board Of Trustees Of The University Of Illinois Magnetic gels which change volume in response to voltage changes for MRI
GB9314499D0 (en) * 1993-07-12 1993-08-25 Nycomed Imaging As Method
US5817632A (en) * 1993-08-16 1998-10-06 Hsia; Jen-Chang Compositions and methods utilizing nitroxides in combination with biocompatible macromolecules
US5741893A (en) * 1993-08-16 1998-04-21 Hsia; Jen-Chang Compositions and methods utilizing nitroxides in combination with biocompatible macromolecules
US5824781A (en) * 1993-08-16 1998-10-20 Hsia; Jen-Chang Compositions and methods utilizing nitroxides in combination with biocompatible macromolecules
US5725839A (en) * 1993-08-16 1998-03-10 Hsia; Jen-Chang Compositions and methods utilizing nitroxides in combination with biocompatible macromolecules for ERI or MRI
US5807831A (en) * 1993-08-16 1998-09-15 Hsia; Jen-Chang Compositions and methods utilizing nitroxides in combination with biocompatible macromolecules
US5804561A (en) * 1993-08-16 1998-09-08 Hsia; Jen-Chang Compositions and methods utilizing nitroxides in combination with biocompatible macromolecules
TW381022B (en) * 1993-08-16 2000-02-01 Hsia Jen Chang Compositions and methods utilizing nitroxides to avoid oxygen toxicity, particularly in stabilized, polymerized, conjugated, or encapsulated hemoglobin used as a red cell substitute
US5840701A (en) * 1993-08-16 1998-11-24 Hsia; Jen-Chang Compositions and methods utilizing nitroxides in combination with biocompatible macromolecules
US5767089A (en) * 1993-08-16 1998-06-16 Hsia; Jen-Chang Compositions and methods utilizing nitroxides in combination with biocompatible macromolecules
EP0650739B1 (en) 1993-10-28 2003-02-26 Medrad, Inc. Total system for contrast delivery
DE69432582T2 (de) 1993-10-28 2003-11-27 Medrad, Inc. System zur Administration von Flüssigkeiten bei mehreren Patienten
GB9416767D0 (en) * 1994-08-18 1994-10-12 Nycomed Innovation Ab Compositions
GB9416768D0 (en) * 1994-08-18 1994-10-12 Nycomed Innovation Ab Compositions
US5863519A (en) * 1994-08-18 1999-01-26 Nycomed Imaging As Composition and method of MRI using both a positive and a negative contrast agent
US5840026A (en) 1994-09-21 1998-11-24 Medrad, Inc. Patient specific dosing contrast delivery systems and methods
GB9420390D0 (en) * 1994-10-10 1994-11-23 Nycomed Salutar Inc Liposomal agents
DK81095A (da) * 1995-07-11 1997-01-12 Henrik S Thomsen Peroralt MR-kontraststof til lever og øvre tarmkanal
US7169410B1 (en) * 1998-05-19 2007-01-30 Sdg, Inc. Targeted liposomal drug delivery system
EP1105162A1 (en) * 1998-08-10 2001-06-13 Bracco Research S.A. Combination of a positive mri contrast agent with a negative mri contrast agent
EP0988864A1 (de) * 1998-09-23 2000-03-29 Luboldt, Wolfgang, Dr.med. Dipl.-Phys. Kontrastmittel für die Magnetresonanztomographie
US7871597B2 (en) 1999-04-09 2011-01-18 Amag Pharmaceuticals, Inc. Polyol and polyether iron oxide complexes as pharmacological and/or MRI contrast agents
PT1169062E (pt) * 1999-04-09 2009-12-17 Amag Pharmaceuticals Inc Óxidos de ferro coloidais termoestáveis revestidos
PL353336A1 (en) * 1999-07-29 2003-11-17 Epix Medical, Inc. Targeting multimeric imaging agents through multilocus binding
US20030120151A1 (en) * 2001-01-10 2003-06-26 Johns Hopkins University Magnetic resonance imaging methods and compositions
US8961541B2 (en) 2007-12-03 2015-02-24 Cardio Vascular Technologies Inc. Vascular closure devices, systems, and methods of use
US20080109030A1 (en) 2001-04-24 2008-05-08 Houser Russell A Arteriotomy closure devices and techniques
US8992567B1 (en) 2001-04-24 2015-03-31 Cardiovascular Technologies Inc. Compressible, deformable, or deflectable tissue closure devices and method of manufacture
US6934574B1 (en) * 2001-06-21 2005-08-23 Fonar Corporation MRI scanner and method for modular patient handling
TWI221406B (en) * 2001-07-30 2004-10-01 Epix Medical Inc Systems and methods for targeted magnetic resonance imaging of the vascular system
US6944492B1 (en) 2001-10-01 2005-09-13 Fonar Corporation Patient bed support for an open MRI system
US7109974B2 (en) * 2002-03-05 2006-09-19 Matsushita Electric Industrial Co., Ltd. Remote control system including an on-screen display (OSD)
US8295914B2 (en) * 2004-11-16 2012-10-23 Medrad, Inc. Systems and methods of determining patient transfer functions and modeling patient response to a pharmaceutical injection
EP2990073B1 (en) 2004-11-24 2018-05-02 Bayer Healthcare LLC Devices and systems for fluid delivery
US8023172B2 (en) * 2006-08-30 2011-09-20 Silicon Quest Kabushiki-Kaisha Mirror device
US20100030073A1 (en) * 2006-12-29 2010-02-04 Medrad, Inc. Modeling of pharmaceutical propagation
DK2097835T3 (da) 2006-12-29 2018-09-03 Bayer Healthcare Llc Patientbaserede parametergenereringssystemer til medicinske injektionsprocedurer
US8195275B2 (en) * 2007-05-23 2012-06-05 Siemens Aktiengesellschaft Vessel size imaging for antiangiogenic therapy
EP2005970A1 (de) 2007-06-22 2008-12-24 Berlin Science Partners GmbH i.V. Bildgebende Diagnostik durch Kombination von Kontrastmitteln
WO2009012288A2 (en) * 2007-07-17 2009-01-22 Government Of The United States Of America, Represented By The Secretary, Department Of Health And Human Services Trifunctional imaging agent for monoclonal antibody tumor-targeted imaging
US8428694B2 (en) * 2007-07-17 2013-04-23 Medrad, Inc. Methods for determination of parameters for a procedure, for estimation of cardiopulmonary function and for fluid delivery
US8608484B2 (en) * 2008-03-04 2013-12-17 Medrad, Inc. Dynamic anthropomorphic cardiovascular phantom
US8315449B2 (en) 2008-06-24 2012-11-20 Medrad, Inc. Identification of regions of interest and extraction of time value curves in imaging procedures
US9421330B2 (en) 2008-11-03 2016-08-23 Bayer Healthcare Llc Mitigation of contrast-induced nephropathy
NZ595417A (en) 2009-04-09 2013-10-25 Cardivascular Systems Tissue closure devices, device and systems for delivery, kits and methods therefor
AU2011270772C1 (en) 2010-06-24 2017-04-20 Bayer Healthcare Llc Modeling of pharmaceutical propagation and parameter generation for injection protocols
AU2012312312B2 (en) 2011-09-21 2017-07-13 Bayer Healthcare Llc Continuous multi-fluid pump device, drive and actuating system and method
FR2986332A1 (fr) * 2012-01-30 2013-08-02 Centre Nat Rech Scient Nanoparticules a luminescence persistante pour l'imagerie optique en temps reel, l'imagerie multimodale optique-irm in vivo, et la theranostique
AU2012380327A1 (en) 2012-05-14 2014-11-27 Bayer Healthcare Llc Systems and methods for determination of pharmaceutical fluid injection protocols based on x-ray tube voltage
US9555379B2 (en) 2013-03-13 2017-01-31 Bayer Healthcare Llc Fluid path set with turbulent mixing chamber, backflow compensator
CN107427411B (zh) 2015-01-09 2021-04-02 拜耳医药保健有限公司 具有多次使用可丢弃套件的多流体递送系统及其特征
EP3423130B1 (en) 2016-03-03 2025-05-14 Bayer Healthcare LLC System and method for improved fluid delivery in multi-fluid injector systems
JP7191821B2 (ja) 2016-11-14 2022-12-19 バイエル・ヘルスケア・エルエルシー 医用流体送出に使用されるシリンジの内容物を確認するための方法およびシステム
AU2018326379B2 (en) 2017-08-31 2024-03-21 Bayer Healthcare Llc Method for dynamic pressure control in a fluid injector system
EP3675930B1 (en) 2017-08-31 2024-01-17 Bayer Healthcare LLC Method for drive member position and fluid injector system mechanical calibration
AU2018326485B2 (en) 2017-08-31 2024-01-04 Bayer Healthcare Llc Injector pressure calibration system and method
WO2019046299A1 (en) 2017-08-31 2019-03-07 Bayer Healthcare Llc FLUID PATH IMPEDANCE ASSESSMENT FOR IMPROVING FLUID DISTRIBUTION PERFORMANCE
EP3675927B1 (en) 2017-08-31 2023-12-13 Bayer Healthcare LLC Fluid injector system volume compensation system and method
JP7754625B2 (ja) 2018-04-19 2025-10-15 バイエル・ヘルスケア・エルエルシー 流体インジェクタ内の空気を検出するためのシステムおよび方法
CN112823031B (zh) 2018-08-28 2023-08-15 拜耳医药保健有限责任公司 防止流体回流的流体注入器系统、方法和计算机程序产品
AU2019332923A1 (en) 2018-08-28 2021-02-11 Bayer Healthcare Llc Fluid injector system with improved ratio performance

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3731377A (en) * 1971-08-19 1973-05-08 W Muckelroy Method for handling beam-lead and odd-shaped semi-conductor devices
JPS53130572A (en) * 1977-04-05 1978-11-14 Tdk Electronics Co Ltd Highhgradient magnetic separator using amorphous magnetic alloy
US4735796A (en) * 1983-12-08 1988-04-05 Gordon Robert T Ferromagnetic, diamagnetic or paramagnetic particles useful in the diagnosis and treatment of disease
US4590922A (en) * 1983-08-19 1986-05-27 Gordon Robert T Use of ferromagnetic, paramagnetic and diamagnetic particles in the treatment of infectious diseases
GB8408127D0 (en) * 1984-03-29 1984-05-10 Nyegaard & Co As Contrast agents
GB8413772D0 (en) * 1984-05-30 1984-07-04 Nyegaard & Co As Chemical compounds
US4889120A (en) * 1984-11-13 1989-12-26 Gordon Robert T Method for the connection of biological structures
US4827945A (en) * 1986-07-03 1989-05-09 Advanced Magnetics, Incorporated Biologically degradable superparamagnetic materials for use in clinical applications
US4813399A (en) * 1986-07-18 1989-03-21 Gordon Robert T Process for the treatment of neurological or neuromuscular diseases and development

Also Published As

Publication number Publication date
EP0414700B1 (en) 1993-10-13
GB8808305D0 (en) 1988-05-11
AU3359889A (en) 1989-11-03
AU624132B2 (en) 1992-06-04
JPH082802B2 (ja) 1996-01-17
EP0414700A1 (en) 1991-03-06
DE68909935D1 (de) 1993-11-18
WO1989009625A1 (en) 1989-10-19
DK239490A (da) 1990-10-04
US5128121A (en) 1992-07-07
JPH03503612A (ja) 1991-08-15
DE68909935T2 (de) 1994-03-17

Similar Documents

Publication Publication Date Title
DK239490D0 (da) Kontrastmidler til magnetisk resonansafbildning
DE69029692D1 (de) Magnetresonanzabbildung
DE69218479D1 (de) Magnetischer Resonanz-Apparat
DE69224354D1 (de) Magnetisches Resonanzverfahren
DE68913879D1 (de) Kernspinresonanzgerät.
DE68907278D1 (de) Supraleitender magnetresonanz-magnet.
DE69028962D1 (de) Magnetresonanzsysteme
DE69130108D1 (de) Abbildung mittels magnetischer Resonanz
DE69024531D1 (de) Bildaufzeichnungsgerät
DE69120600D1 (de) Magnetisches Aufzeichnungssystem
DE69326379D1 (de) Kinematographische Bilderzeugung mittels magnetischer Resonanz
FI863407A0 (fi) Magnetisk resonansavbildningsapparat innehaollande magnetiska element avsedda foer faelthomogenisering.
DE69332215D1 (de) Bilderzeugung mittels magnetischer Resonanz
DE69428628D1 (de) Gradientenspule
IT1230495B (it) Toner magnetico
DE3689873D1 (de) Bilderzeugung mittels magnetischer Kernresonanz.
FI875274A7 (fi) Gradienttikela magneettista resonanssikuvauslaitetta varten.
DE69029827D1 (de) Schnelles Multimode-Magnetresonanz-Abbildungsverfahren
DE69320094D1 (de) Kernspinresonanzapparat
GB8813425D0 (en) Magnetic resonance imaging
DE69129362D1 (de) Bilderzeugung mittels magnetischer Resonanz
DE3855944D1 (de) Kernresonanzabbildungssystem
DE69117022D1 (de) Magnetisches Aufzeichnungssystem
DE58909771D1 (de) Kernresonanz-Spektrometer
DE69225564D1 (de) Magnetische Resonanzanordnung

Legal Events

Date Code Title Description
AHB Application shelved due to non-payment